Related Experiment Videos

Production and characterization of new monoclonal antibodies to human osteoclasts

P N Nelson1, J A Pringle, T J Chambers

  • 1Department of Histopathology, St. George's Hospital Medical School, London, U.K.

Calcified Tissue International
|November 1, 1991
PubMed

Insights

Two monoclonal antibodies targeting human osteoclastoma demonstrated anti-osteoclastic activity. These antibodies may recognize unique epitopes specific to human osteoclasts, not found on other cells or species.

Area of Science:

  • Immunology
  • Oncology
  • Cell Biology

Background:

  • Osteoclastoma is a bone tumor characterized by the presence of osteoclasts.
  • Monoclonal antibodies are valuable tools for studying cell-specific markers and functions.
  • Understanding osteoclast-specific targets is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the potential of monoclonal antibodies raised against human osteoclastoma for targeting osteoclasts.
  • To characterize the reactivity and specificity of these antibodies.

Main Methods:

  • Generation of monoclonal antibodies against human osteoclastoma.
  • Testing antibody activity on frozen tumor sections.
  • Immunohistochemical analysis on various human tissues and animal osteoclasts.

Main Results:

  • Two monoclonal antibodies exhibited anti-osteoclastic activity on human osteoclastoma sections.
  • Immunoreactivity was observed on the cell membrane surface.
  • Antibodies showed no activity against tissue macrophages or most human visceral tissues, except for kidney tubules.
  • No activity was detected against rabbit or rat osteoclasts.

Conclusions:

  • The developed monoclonal antibodies possess anti-osteoclastic activity.
  • These antibodies likely target unique epitopes present on human osteoclasts.
  • The findings suggest potential for developing targeted therapies for osteoclastoma.

Related Concept Videos